Finally their is so good new about the fight to find the cure for Alzheimer's Disease
 

Experimental Alzheimer's drug may slow cognitive decline
The experimental intravenous drug donanemab may slow cognitive decline in people living with Alzheimer's, according to a Phase 2 clinical trial. Researchers found that the drug slowed the decline of cognition and daily function in participants by 32 percent after 76 weeks compared to those who received a placebo. The research is early, but Maria Carrillo, Alzheimer’s Association chief science officer, says the drug “could be a first step toward slowing more significantly, or stopping, cognitive decline in these earlier stages."
:)

That would be so great. Mom has had this for 15 years. Dad started last year. I take care of both. So sad to watch, but glad they are still with us.

Right now I like the prospect of A273 from Anavex Life Sciences even better. It's also being tested on Parkinson's Disease and Rett Syndrome. In addition, they hope to test it on several other CNS diseases. They take a completely different avenue attacking brain issues than big pharma does.

Ouch, you've got a rough road ahead, best of luck to you all

Thank you. Working on my seat in haven. Had a week off now back to 7 days a week.

I am so sorry to read this. I think about all of you often and wondered how they were doing. You are a good son.